Ads
related to: kesimpta multiple sclerosis- Multiple Sclerosis Events
Connect Online Or In-Person
Attend Patient Education Events
- Prescribing Information
Find The Prescribing Information
For An MS Treatment Option
- Doctor Discussion Guide
Use This Guide To Help Aid In
Conversations With Your Doctor
- Medication Guide
Read Medication Information On A
MS Treatment Option
- Safety & Side Effects
View Possible Infusion Reactions
For An MS Treatment Option
- Real Patient Videos
Watch Videos Of Real Patients And
How They Don't Let MS Define Them
- Multiple Sclerosis Events
Search results
Novartis Says Relapsing Multiple Sclerosis Patients Remained Free From Disease Progression For Up...
Benzinga via Yahoo Finance· 1 year agoNovartis AG (NYSE: NVS) announced new long-term data from the ALITHIOS open-label extension study of...
Experimental Therapies for Multiple Sclerosis (MS)
Verywell Health via Yahoo News· 2 years agoThe goal of multiple sclerosis (MS) treatment is to slow or stop the immune system's attack on the nervous system. This article reviews the latest...
What Is the First Line of Treatment for Multiple Sclerosis?
Verywell Health via Yahoo News· 2 years agoMedically reviewed by Lindsay Cook, PharmD In multiple sclerosis (MS), the immune system attacks the...
Genmab: Growth Is Still a Better Choice
GuruFocus.com via Yahoo Finance· 3 months agoGenmab AS (NASDAQ:GMAB) is one of the largest Danish pharmaceutical companies focused on developing medicines to treat patients with cancer, multiple...
Top-Notch Biotech TG Therapeutics Breaks Out On 'Solid Jump' In Sales
Investor's Business Daily· 1 year agoTG Therapeutics' new multiple sclerosis drug, Briumvi, experienced a "solid jump" in March sales,...
Novartis Stock Hits Record High On A Trio Of First-Quarter Drivers
Investor's Business Daily· 1 year agoNovartis stock jumped to a record high Tuesday after a trio of drugs — including blockbuster heart...
Novartis (NVS) to Divest Xiidra, SAF312 to Streamline Focus
Zacks via Yahoo Finance· 11 months agoNovartis NVS, a leading pharmaceutical company, recently made a strategic decision to divest its...
Novartis sees brighter sales future as R&D revamp continues
BioPharma Dive via Yahoo Finance· 6 months agoDive Brief: Novartis expects sales to grow faster than anticipated over the next five years as...
UPDATE 1-U.S. FDA approves TG Therapeutics' multiple sclerosis drug
Reuters via Yahoo Finance· 1 year agoThe U.S. health regulator on Wednesday approved TG Therapeutics Inc's drug for patients with relapsing forms of multiple sclerosis, pitting it against rivals from Roche and Novartis. The drug ...
Novartis (NVS) Tops Q3 Earnings, Ups Operating Income View
Zacks via Yahoo Finance· 7 months agoSwiss pharma giant Novartis AG NVS reported strong sales from key drugs in third-quarter 2023 and...
Ads
related to: kesimpta multiple sclerosis
